rs149975740
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012419.5(RGS17):c.598G>C(p.Val200Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,610,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012419.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS17 | NM_012419.5 | c.598G>C | p.Val200Leu | missense_variant | Exon 5 of 5 | ENST00000206262.2 | NP_036551.3 | |
RGS17 | XM_047418634.1 | c.643G>C | p.Val215Leu | missense_variant | Exon 5 of 5 | XP_047274590.1 | ||
RGS17 | XM_047418635.1 | c.631G>C | p.Val211Leu | missense_variant | Exon 5 of 5 | XP_047274591.1 | ||
RGS17 | XM_047418636.1 | c.598G>C | p.Val200Leu | missense_variant | Exon 5 of 5 | XP_047274592.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249576 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1458702Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 725806 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74288 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.598G>C (p.V200L) alteration is located in exon 5 (coding exon 4) of the RGS17 gene. This alteration results from a G to C substitution at nucleotide position 598, causing the valine (V) at amino acid position 200 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at